<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Peroxisome proliferator-activated receptor-gamma (PPARgamma), a member of the nuclear receptor superfamily, has been detected in several human <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells </plain></SENT>
<SENT sid="1" pm="."><plain>Recent studies reported that PPARgamma ligands inhibit cell proliferation and induce <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in both <z:mpath ids='MPATH_458'>normal</z:mpath> and malignant B-lineage cells </plain></SENT>
<SENT sid="2" pm="."><plain>We investigated the expression of PPARgamma and the effects of PPARgamma ligands on UTree-O2, Bay91 and 380, three B-cell <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (<z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e>) cell lines with t(14;18), which show a poor prognosis, accompanying c-myc abnormality </plain></SENT>
<SENT sid="3" pm="."><plain>Western blot analysis identified expression of PPARgamma protein and real-time PCR that of PPARgamma <z:chebi fb="2" ids="33699">mRNA</z:chebi> on the three cell lines </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="9753">Troglitazone</z:chebi> (TGZ), a synthetic PPARgamma ligand, inhibited cell growth in these cell lines in a dose-dependent manner, which was associated with G(1) cell cycle arrest and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>We also found this effect PPARgamma independent since PPARgamma <z:chebi fb="68" ids="48706">antagonists</z:chebi> failed to reverse this effect </plain></SENT>
<SENT sid="6" pm="."><plain>We assessed the expression of c-myc, an <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-regulatory gene, since c-myc abnormality was detected in most <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> cells with t(14;18) </plain></SENT>
<SENT sid="7" pm="."><plain>TGZ was found to dose-dependently downregulate the expression of c-myc <z:chebi fb="2" ids="33699">mRNA</z:chebi> and c-myc protein in the three cell lines </plain></SENT>
<SENT sid="8" pm="."><plain>These results suggest that TGZ inhibits cell growth via induction of G(1) cell cycle arrest and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in these cell lines and that TGZ-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, at least in part, may be related to the downregulation of c-myc expression </plain></SENT>
<SENT sid="9" pm="."><plain>Moreover, the downregulation of c-myc expression by TGZ may depend on a PPARgamma-independent mechanism </plain></SENT>
<SENT sid="10" pm="."><plain>Further studies indicate that PPARgamma ligands may serve as a therapeutic agent in <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> with t(14;18) </plain></SENT>
</text></document>